🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Researches About Proximal Humerus Fractures

Recruitingn/aAges 17 Years - anyAllHebei Medical University Third Hospital
NCT04523415 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Majority of previous classifications based on two-dimensional images to analyze these complicated 3-D fractures. Small or delicate changes in rotation and positioning can result to considerable disagreement in the interpretation of standard radiographs. Therefore, a classification system which had a better reliability and reproducibility for the fractures is warranted and helpful for orthopedic surgeons. Furthermore, CT and 3-D CT construction images with high resolution give a much clearer view of the pattern of proximal humeral fractures. Edelson proposed a new three-dimensional classification for fractures of the proximal humerus. The results concluded that it was a useful in classifying these injuries with reasonable interobserver reliability. It could be hypothesized that patients with proximal humeral fractures would benefit from this 3D classification, but there is a scarcity of

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Whole imaging data ; * Clear record of demographic data; * Three dimensional construction with mimics (with CT of B30); * Patients older than 17 years with displaced PHF occurring less than 3 weeks before allocation and treatment. Exclusion Criteria: * Patients with the presence of neurological disease (syringomyelia and); * Open fractures; * Pathological fracture (other than osteoporotic); * Not a resident in the hospital catchment area
💊

What it tests

  • without intervention, just retrospectively review the data about patients
📍

Where

1 site
the Third Hospital of Hebei Medical University
Shijiazhuang, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy